Myelodysplastic Syndrome
From the Journals
Clonal hematopoiesis increases risk for therapy-related cancers
Small pre-leukemic clones left behind after treatment for non-myeloid malignancies appear to increase the risk for therapy-related myelodysplasia...
Conference Coverage
PERSIST-2 might allay some concerns about pacritinib in myelofibrosis
SAN DIEGO – Late-breaking results from the phase III PERSIST-2 trial may ease at least some safety concerns surrounding the use of pacritinib in...
Conference Coverage
Adding epoetin alfa to lenalidomide boosted myelodysplastic syndrome responses
SAN DIEGO – Dual therapy with lenalidomide and epoetin alfa was safe and led to freedom from transfusion significantly more often than...
News
Study reveals potential therapeutic targets for MDS
Preclinical research has revealed potential therapeutic targets for myelodysplastic syndromes (MDS). Investigators found evidence to suggest...
Conference Coverage
MDS patients with mutated IDH2 benefit from enasidenib
Photo courtesy of ASH SAN DIEGO—Daily treatment with enasidenib monotherapy in patients with mutated IDH2-positive myelodysplastic syndromes (MDS...
Conference Coverage
Predicting therapy-related myeloid neoplasms
Photo courtesy of MD Anderson Cancer Center SAN DIEGO―Clonal hematopoiesis could be used as a predictive marker to identify cancer patients at...
News
Decitabine produces responses in high-risk MDS, AML
receiving chemotherapy Photo by Rhoda Baer Patients with TP53-mutated myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) may benefit...
News
Inflammation may predict transformation to AML
Inflammatory signaling in mesenchymal niche cells can be used to predict the transformation from pre-leukemic syndrome to acute myeloid leukemia (...
News
Teva launches generic imatinib tablets in US
Photo by Steven Harbour Teva Pharmaceutical Industries Ltd.
News
Method provides more accurate diagnosis of MDS, team says
Next-generation sequencing (NGS) of cell-free DNA should be the method of choice to confirm the diagnosis of myelodysplastic syndromes (MDS),...
News
Radiologists no longer have higher risk of cancer-related death
Photo by Rhoda Baer Radiologists who graduated from medical school after 1940 do not have an increased risk of dying from radiation-related...